Laws And Regulations

Type	Signature	Number	Date	Topic	Document
Circular	Minister of Public Health	9	9-3-2022	Related to providing specialized mental health medications in primary health care centers	Circular Number 9: Related to providing specialized mental health medications in primary health care centers
Decision	Minister of Public Health	271/1	25/02/2019	Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital	Decision Number 271/1: Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital
Decision	Minister of Public Health	270/1	25/02/2019	Related to the Quality of Care and Human Rights in the Field of Mental Health	Decision Number 270/1: Related to the Quality of Care of Human Rights in the Field of Mental Health
Circular	Director General	60	20/06/2018	Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system	Circular Number 60: Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system
Circular	Director General	112	27/11/2018	Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health	Circular Number 112: Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health
Circular	Director General	113	22/11/2018	Related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)	Circular number 113: related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)
Decision	Minister of Public Health	1155	19-06-2018	Decision related to the National Mental Health Programme	Decision number 1155: related to the National Mental Health Programme
Circular	Director General	22	09-03-2018	Regulation of studies and research in the field of mental health and psychosocial support	Circular number 22: related to the regulation of studies and research in the field of mental health and psychosocial support
Annexe		1320/1	02-2018	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.
Circular	Director General	48	12-06-2017	Regulation of research in the field of mental health	Circular number 48: Related to the regulation of research in the field of mental health
Circular	Director General	64	12-06-2017	Projects related to MHPSS and substance use in Lebanon	Circular number 64: Projects related to MHPSS and substance use in Lebanon
Circular	Director General	46	22-03-2016	Request to hospitals to not report on overdose	Circular number 46: related to the request to hospitals to not report on overdose
Circular	Director General	66	20-6-2025	Regarding Specialized Mental Health Medications	Circular number 66: Concerning Specialized Mental Health Medications

ATC	Name	B/G	Ingredients	Dosage	Form	Price
L04AX04	REVLIMID	B	Lenalidomide - 15mg	15mg	Capsule	116,241,703 L.L
N02BF02	LYRICA	B	Pregabalin - 75mg	75mg	Capsule	598,010 L.L
N06DX01	EBIXA	B	Memantine - 20mg	20mg	Tablet, film coated	4,004,651 L.L
S01EE04	TRAVATAN	B	Travoprost - 40mcg/ml	0.004%	Drops solution	806,306 L.L
A06AB58	PICOPREP	B	Magnesium oxide - 3.5g, Citric acid - 12g, Sodium picosulfate - 10mg		Powder	694,767 L.L
B01AF01	XARELTO	B	Rivaroxaban - 2.5mg	2.5mg	Tablet, film coated	4,045,168 L.L
D07AB02	LOCOID CRELO 0.1%	B	Hydrocortisone butyrate - 1mg/g	0.1%	Emulsion	177,387 L.L
M04AA03	ADENURIC	B	Febuxostat - 80mg	80mg	Tablet, film-scored	2,127,111 L.L
N02BF02	LYRICA	B	Pregabalin - 75mg	75mg	Capsule	2,131,334 L.L
D07AB02	LOCOID CRELO 0.1%	B	Hydrocortisone butyrate - 1mg/g	0.1%	Emulsion	177,387 L.L
G03GB02	CLOMID	B	Clomifene citrate - 50mg	50mg	Tablet	274,144 L.L
N02BF02	LYRICA	B	Pregabalin - 75mg	75mg	Capsule	598,010 L.L
N05AX08	RISPERDAL	B	Risperidone - 1mg/ml	1mg/ml	Solution	1,377,439 L.L
L01ED05	LORBRENA	B	Lorlatinib - 100mg	100mg	Tablet	L.L
A10BD20	SYNJARDY	B	Empagliflozin - 12.5mg, Metformin HCl - 850mg	12.5mg/850mg	Tablet, film coated	3,287,711 L.L
B01AF01	XARELTO	B	Rivaroxaban - 15mg	15mg	Tablet, film coated	4,440,862 L.L
C01EB17	PROCORALAN	B	Ivabradin (HCl) - 7.5mg	7.5mg	Tablet, film coated	1,890,786 L.L
D07AB02	LOCOID	B	Hydrocortisone butyrate - 0.1%	0.1%	Lotion	201,576 L.L
J05AF13	VEMLIDY	B	Tenofovir alafenamide fumarate - 25mg	25mg	Tablet, film coated	26,997,299 L.L
L01XG02	KYPROLIS	B	Carfilzomib - 60mg	60mg	Injectable powder for solution	96,642,005 L.L
N05AX08	RISPERDAL	B	Risperidone - 1mg/ml	1mg/ml	Solution	1,377,439 L.L
R03DX10	FASENRA	B	Benralizumab - 30mg	30mg	Injectable solution	214,213,273 L.L
L01EA04	BOSULIF	B	Bosutinib - 100mg	100mg	Tablet, film coated	L.L
A01AD11	PYRALVEX	B	Salicylic acid - 0.01g/ml, Rhubarb (Anthraquinone Glycosides) - 0.05g/ml		Solution	327,898 L.L
A06AD11	DUPHALAC	B	Lactulose - 6.7g/10ml	6.7g/10ml	Solution	454,219 L.L
A10BD20	SYNJARDY	B	Empagliflozin - 5mg, Metformin HCl - 850mg	5mg/850mg	Tablet, film coated	3,287,711 L.L
C09BA03	ZESTORETIC	B	Lisinopril (dihydrate) - 20mg, Hydrochlorothiazide - 12.5mg		Tablet	663,858 L.L
D07AB02	LOCOID	B	Hydrocortisone butyrate - 0.1%	0.1%	Lotion	201,576 L.L
J01FA09	KLACID	B	Clarithromycin - 500mg	500mg	Tablet, film coated	1,329,060 L.L
L01XG03	NINLARO	B	Ixazomib - 4mg	4mg	Capsule, hard	388,991,058 L.L